Latest Molecular imaging Stories
PHOENIX, July 18, 2011 /PRNewswire/ -- Today in Phoenix, Cardinal Health opened The Center for the Advancement of Molecular Imaging (The Center) - a new, first-of-its-kind collaboration laboratory that will expedite the development of nuclear imaging agents that treat complex diseases like cancer, heart disease and neurological disorders.
CULVER CITY, Calif., July 7, 2011 /PRNewswire/ -- Sofie Biosciences, developer of molecular imaging systems and probes, has been awarded a 2011 Phase I Small Business Innovation Research grant from the Department of Energy.
CAGE Chemicals, University of Turin and Aspect Imaging to Develop Applications and Products for Molecular Imaging on Aspect's M2(TM) Compact MRI System for Preclinical Imaging TORONTO, Canada, SHOHAM, Israel, and TURIN, Italy, June 29, 2011 /PRNewswire/ - Aspect Imaging today announced its agreement with CAGE Chemicals to develop and manufacture Aspect's PhenoQuant(TM) line of contrast agents for preclinical research.
AUGUSTA, Ga., June 14, 2011 /PRNewswire/ -- Cardinal Health today opened its first cyclotron facility in the state of Georgia, further expanding its nationwide capability to manufacture molecular imaging biomarkers that aid in the early diagnosis, monitoring and treatment of cancer, neurological disorders and heart disease. Cyclotrons are critical to the manufacturing process for Positron Emission Tomography (PET) molecular imaging agents, one of the fastest-growing areas of nuclear medicine.
OXFORD, United Kingdom, June 6, 2011 /PRNewswire/ -- Oxford BioMedicaplc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that it has signed a research collaboration agreement with ImaginAb, Inc.
SAN ANTONIO, June 3, 2011 /PRNewswire/ -- At the 2011 SNM Annual Meeting in San Antonio, Siemens Healthcare (booth #6033) will address the increasing demand for molecular imaging procedures and Siemens' efforts to expand molecular imaging's availability in three directions: patient access, clinical utilization, and new clinical applications.
NEWPORT NEWS, Va., June 2, 2011 /PRNewswire/ -- Dilon Diagnostics will introduce the latest advancement in molecular breast imaging (MBI) this week at the Society of Nuclear Medicine (SNM) Meeting in San Antonio, Texas, with the premiere of its FDA-cleared Dilon 6800Â® Acella Gamma Camera system.
SAN DIEGO, May 3, 2011 /PRNewswire/ -- Researchers from the University of Cincinnati presented results from a prospective study at the American Roentgen Ray Society 2011 Annual Meeting today, demonstrating how PEM-guided biopsy may expedite pre-operative work-up and reduce radiation exposure for breast cancer patients.
LOS ANGELES, April 18, 2011 /PRNewswire/ -- ImaginAb, Inc.
- The act of sweetening by admixture of some saccharine substance.